![](https://www.texasretina.com/wp-content/uploads/2024/07/Wang-ASRS-2024.png)
Robert C. Wang, MD, Presented Initial Study Results of New Non-infectious Uveitis Treatment at ASRS 2024 Annual Meeting
Texas Retina’s Robert C. Wang, MD, presented “Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase II Study (NEPTUNE)” at the 2024 Annual
read more![](https://www.texasretina.com/wp-content/uploads/2024/07/Abbey-ASRS-2024.png)
Ashkan M. Abbey, MD, Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read more![](https://www.texasretina.com/wp-content/uploads/2024/02/Laura-Settles-reduced.jpg)
Texas Retina Recognizes Laurie Griffis for 35 Years of Service
Since Texas Retina was founded more than 50 years ago, our physicians and leadership have fostered a family environment. As a result, we are fortunate to have numerous team members who have
read more![](https://www.texasretina.com/wp-content/uploads/2023/11/Founders-Blog-Photo-1.jpg)
Celebrating Our Visionary Founders
Many of our “founding physicians” met for dinner this past weekend, including Albert Vaiser, MD, and William Hutton, MD, who along with William Snyder, MD, established Texas Retina Associates more than 50 years
read more![](https://www.texasretina.com/wp-content/uploads/2022/06/Abbey-Ashkan-08-Blog-Head-Shot-1.jpg)
Dr. Abbey Publishes Case Report on Macular Hole Closure with Intravitreal Dexamethasone Implant
In the September 2023 issue of the peer-reviewed medical journal Ophthalmic Surgery, Lasers and Imaging Retina, Texas Retina’s Ashkan Abbey, MD, describes the use of a dexamethasone intravitreal implant to close a
read more![](https://www.texasretina.com/wp-content/uploads/2022/06/Abbey-Ashkan-08-Blog-Head-Shot-1.jpg)
Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy
Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan
read more